Outcomes of SARS-CoV-2 omicron infection in residents of long-term care facilities in England (VIVALDI): a prospective, cohort study
…, M Shrotri, A Irwin-Singer, V Baynton… - The Lancet Healthy …, 2022 - thelancet.com
Background The SARS-CoV-2 omicron variant (B.1.1.529) is highly transmissible, but disease
severity appears to be reduced compared with previous variants such as alpha and delta. …
severity appears to be reduced compared with previous variants such as alpha and delta. …
Duration of vaccine effectiveness against SARS-CoV-2 infection, hospitalisation, and death in residents and staff of long-term care facilities in England (VIVALDI): a …
…, C Fuller, A Irwin-Singer, V Baynton… - The Lancet Healthy …, 2022 - thelancet.com
Background Residents and staff in long-term care facilities have been prioritised for vaccination
against SARS-CoV-2, but data on potential waning of vaccine effectiveness and the …
against SARS-CoV-2, but data on potential waning of vaccine effectiveness and the …
Antibody and cellular immune responses following dual COVID-19 vaccination within infection-naive residents of long-term care facilities: an observational cohort …
…, M Shrotri, B Azmi, C Fuller, V Baynton… - The Lancet Healthy …, 2022 - thelancet.com
Background Older age and frailty are risk factors for poor clinical outcomes following SARS-CoV-2
infection. As such, COVID-19 vaccination has been prioritised for individuals with …
infection. As such, COVID-19 vaccination has been prioritised for individuals with …
Strong peak immunogenicity but rapid antibody waning following third vaccine dose in older residents of care homes
Third-dose coronavirus disease 2019 vaccines are being deployed widely but their efficacy
has not been assessed adequately in vulnerable older people who exhibit suboptimal …
has not been assessed adequately in vulnerable older people who exhibit suboptimal …
Clinical effectiveness of SARS-CoV-2 booster vaccine against Omicron infection in residents and staff of Long-Term Care Facilities: a prospective cohort study …
…, C Fuller, A Irwin-Singer, V Baynton… - Open Forum …, 2023 - academic.oup.com
Background Successive severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
variants have caused severe disease in long-term care facility (LTCF) residents. Primary …
variants have caused severe disease in long-term care facility (LTCF) residents. Primary …
Severe acute respiratory syndrome coronavirus 2 anti-spike antibody levels following second dose of ChAdOx1 nCov-19 or BNT162b2 vaccine in residents of long …
…, R Giddings, H Nacer-Laidi, V Baynton… - The Journal of …, 2022 - academic.oup.com
General population studies have shown strong humoral response following severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination with subsequent waning of anti-…
respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination with subsequent waning of anti-…
Booster vaccination strongly enhances SARS-CoV-2-specific antibody and cellular responses in elderly residents of care homes
…, R Giddings, M Shrotri, B Azmi, C Fuller, V Baynton… - 2021 - papers.ssrn.com
Third dose ‘booster’COVID-19 vaccines can increase SARS-CoV-2 specific immune
responses and are being deployed widely to control the impact of omicron variant infection. …
responses and are being deployed widely to control the impact of omicron variant infection. …
SARS-CoV-2 anti-spike antibody levels following second dose of ChAdOx1 nCov-19 or BNT162b2 in residents of long-term care facilities in England (VIVALDI)
…, S Hulme, R Giddings, H Nacer-Laidi, V Baynton… - medRxiv, 2022 - medrxiv.org
Background General population studies have shown strong humoral response following
SARS-CoV-2 vaccination with subsequent waning of anti-spike antibody levels. Vaccine-…
SARS-CoV-2 vaccination with subsequent waning of anti-spike antibody levels. Vaccine-…
Duration of vaccine effectiveness against SARS-CoV2 infection, hospitalisation, and death in residents and staff of Long-Term Care Facilities (VIVALDI): a prospective …
…, R Giddings, C Fuller, A Irwin-Singer, V Baynton… - medRxiv, 2022 - medrxiv.org
Background Long-term care facilities (LTCF) have been prioritised for vaccination, but data
on potential waning of vaccine effectiveness (VE) and the impact of booster doses in this …
on potential waning of vaccine effectiveness (VE) and the impact of booster doses in this …
Strong peak immunogenicity but rapid antibody waning following third vaccine dose in elderly residents of care homes (preprint)
Third dose COVID-19 vaccines are being deployed widely but their efficacy has not been
assessed adequately in vulnerable elderly people who exhibit suboptimal responses after …
assessed adequately in vulnerable elderly people who exhibit suboptimal responses after …
